TABLE 1

Clinical characteristics of participants

AllType 1 diabetesType 2 diabetesP
n893257
Age (years)53 ± 1444 ± 1559 ± 9<0.0001
Men48 (54)14 (44)34 (60)NS
Diabetes duration (years)15 ± 1525 ± 169 ± 9<0.0001
BMI (kg/m2)29.2 ± 6.525.3 ± 3.831.4 ± 6.7<0.0001
Systolic blood pressure (mmHg)128 ± 19122 ± 16132 ± 200.023
Diastolic blood pressure (mmHg)77 ± 973 ± 879 ± 90.002
Fasting glucose (mg/dl)177 ± 79195 ± 86164 ± 70NS
HbA1c (%)7.5 ± 1.47.8 ± 1.07.3 ± 1.5NS
Total cholesterol (mg/dl)186 ± 32187 ± 28185 ± 34NS
LDL cholesterol (mg/dl)101 ± 28104 ± 21100 ± 31NS
HDL cholesterol (mg/dl)59 ± 1669 ± 1854 ± 11<0.0001n
Triglycerides (mg/dl)132 ± 10571 ± 55166 ± 111<0.0001
Urine albumin/creatinine ratio (mg/g)24 ± 5012 ± 1532 ± 61<0.01
Antihypertensive treatment
    No treatment46 (53)23 (72)23 (40)
    β-Blockers3 (3)03 (5)
    ACE inhibitors23 (26)7 (22)16 (28)
    Diuretics2 (2)02 (4)
    Calcium antagonists3 (3)03 (5)
    Combination10 (12)2 (6)8 (15)
Diabetes treatment
    Diet11 (13)11 (19)
    Oral agents38 (43)38 (67)
    Insulin40 (45)32 (100)8 (14)
Statin treatment23 (26)4 (13)19 (33)
Aspirin17 (19)2 (6)15 (26)
  • Data are means ± SD or n (%). P values indicate differences between type 1 and type 2 diabetes.